B.R.A.H.M.S PCT sensitive KRYPTOR
Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens. De Novo DEN150009, from Brahms GmbH (Henningsdorf, DE). Product code PMT, class 2.
As of Nov 19, 2026, DEN150009 is an FDA De Novo held by Brahms GmbH, granted on Feb 20, 2016 after 353 days, with no recalls tied to it in FDA's recall database.
- Review time: 353 days
- Recalls: 0
- Cited as a predicate by: 7 devices
- Design
- Prospective, multicenter (13 US sites) MOSES study of severe sepsis/septic shock ICU patients, observational, with PCT change as prognostic test
- Enrolled
- 858
- Where
- 13 sites, US
- Primary endpoint
- Association of PCT percent change (Day 0/1 to Day 4, >80% decline vs. <=80%) with cumulative 28-day all-cause mortality
- Result
- Fisher's exact test p=0.002 for association with 28-day mortality (analysis population n=598); Cox HR 2.02 (95% CI 1.27-3.23)
- B·R·A·H·M·S MR-proADM KRYPTOR; B·R·A·H·M·S MR-proADM KRYPTOR CAL; B·R·A·H·M·S MR-proADM KRYPTOR QCK260302 · B·R·A·H·M·S GmbH (part of Thermo Fisher Scientific) · Oct 23, 2026
- Dimension EXL LOCI BRAHMS Procalcitonin (PCT)K220262 · Siemens Healthcare Diagnostics, Inc. · Aug 26, 2022
- Atellica IM BRAHMS Procalcitonin (PCT)K181002 · Siemens Healthcare Diagnostics, Inc. · Jul 16, 2018
- B R A H M S PCT sensitive KRYPTORK171338 · Brahms GmbH · May 31, 2017
- SeptiCyte LABK163260 · Immunexpress, Inc. · Feb 17, 2017
- Vidas B.R.A.H.M.S. Pct (Pct)K160911 · bioMerieux, Inc. · Jun 28, 2016
- Elecys BRAHMS PCT, Elecys BRAHMS PCT CalCheck 5K160729 · Roche Diagnostics · Jun 13, 2016
- Document
- De Novo decision summary (PDF) ↗
- Type
- Direct
- Received
- Mar 4, 2015
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3215
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files